GrafixPL PRIME
Biological
Osiris Therapeutics Inc.
Total Payments
$127,871
Transactions
10
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $127,871 | 10 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $124,996 | 8 | 97.8% |
| Unspecified | $2,875 | 2 | 2.2% |
Payments by Type
General
$124,996
8 transactions
Research
$2,875
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PROTOCOL 360 | Osiris Therapeutics Inc. | $2,875 | 0 |
Ad
Manufacturing Companies
- Osiris Therapeutics Inc. $127,871
Product Information
- Type Biological
- Total Payments $127,871
- Total Doctors 3
- Transactions 10
About GrafixPL PRIME
GrafixPL PRIME is a biological associated with $127,871 in payments to 3 healthcare providers, recorded across 10 transactions in the CMS Open Payments database. The primary manufacturer is Osiris Therapeutics Inc..
Payment data is available from 2018 to 2018. In 2018, $127,871 was paid across 10 transactions to 3 doctors.
The most common payment nature for GrafixPL PRIME is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($124,996, 97.8% of total).
GrafixPL PRIME is associated with 1 research study, including "PROTOCOL 360" ($2,875).